HOME >> MEDICINE >> NEWS
The Lancet Neurology November press release

It is well known in media circles that including the word "sex" in a headline is a sure-fire way of attracting the attention of potential readers. It is understandable, therefore, why a paper published in the Journal of Neurology, Neurosurgery, and Psychiatry (JNNP) entitled "Is multiple sclerosis a sexually transmitted infection?" was well covered by the UK media on Sept 19. Unfortunately, however, the news stories understandably upset many patients with multiple sclerosis. This month's Leading edge (http://neurology.thelancet.com/journal/vol1/iss7/full/lneu.1.7.the_leading_edge.22731.1) discusses who, if anyone, was to blame for this and asks what the lay media, academic journals, scientists, and the general public should expect from each other.

Cyclo-oxygenase inhibitors and Alzheimer's: are we well adapted?

On Sept 4, 2002, the Public Citizen Health Research Group (PCHRG; Washington, DC, USA) sent a letter to US Secretary of Health and Human Services, Tommy Thompson, regarding the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT), which is sponsored by the National Institute on Aging. In the letter, PCHRG called ADAPT "misleading and incomplete..." and said that there are "major problems...with the scientific premise upon which the study is based". In a Reflection and Reaction article (http://neurology.thelancet.com/journal/vol1/iss7/full/lneu.1.7.reflection_and_reaction.22777.1) Giulio Maria Pasinetti and colleagues (Neuroinflammation Research Laboratories, Mount Sinai School of Medicine, New York, USA) summarise the recent evidence supporting preventative anti-inflammatory clinical trials in Alzheimer's disease,and objectively revisit the key studies cited by PCHRG. The authors commentary reinforces the scientific pre
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
16-Oct-2002


Page: 1 2

Related medicine news :

1. The Lancet calls for the creation of a world institute for risk evaluation
2. The Lancet calls for creation of Intl Commission on Global Responses to Complex Emergencies
3. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
4. The Lancet Oncology (TLO)
5. The Lancet Infectious Diseases (TLID)
6. Lancet readers to join WHO election debate
7. The Lancet Oncology press release
8. The Lancet Neurology October press release
9. The Lancet neurology press release
10. The Lancet Neurology press release
11. The Lancet Oncology (TLO) and the Lancet Infectious Diseases (TLID)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... ... , ... The value of healthy vision can’t be overstated, and the most ... care doctor, Brent Bellotte MD., champions such proactive care, advising that annual examinations are ... something that many take for granted until a problem occurs. Eye disease is very ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... a workplace of the future powered by the Myant Platform at CES ... how an office environment connected to the Myant Platform will be aware of ...
(Date:1/7/2020)... Texas (PRWEB) , ... January 07, 2020 , ... ... today unveiled another facility expansion, adding to the company’s 200,000 sq. ft. manufacturing ... 25,000 sq. ft. of manufacturing space dedicated to POD architectural, mechanical, electrical and ...
(Date:1/7/2020)... NEW YORK (PRWEB) , ... January 07, 2020 , ... ... launched a year-long Facebook fundraiser to help others living with YOPD attend the 6th ... fundraiser for two weeks, running back to back to cover all 52 weeks in ...
(Date:1/7/2020)... ... January 07, 2020 , ... R3 ... which includes comprehensive presentations and procedures for hair restoration, facial rejuvenation and sexual ... available. , Regenerative aesthetics has become incredibly popular over the past few years ...
Breaking Medicine News(10 mins):
(Date:1/8/2020)... , ... January 08, 2020 ... ... that they are now able to accept Medicare for medication-assisted treatment services ... with methadone, buprenorphine and naltrexone, all FDA-approved medications, as well as counseling, ...
(Date:1/7/2020)... ... January 07, 2020 , ... Valencell ... system for integration in hearables and wearables. Valencell will provide the BP sensor ... inclusion in their products. Embedded in an earbud reference design, the technology has ...
(Date:1/7/2020)... (PRWEB) , ... January 06, 2020 , ... Myant Inc., ... enable continuous and ambient heart health management at CES 2020 (January 7-10, Las Vegas), ... a winner in the Health & Wellness category of the CES 2020 Innovation Awards. ...
Breaking Medicine Technology:
Cached News: